382 results on '"Von Laer, Dorothee"'
Search Results
2. Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
3. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
4. Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
5. Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
6. Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population
7. Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot
8. A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition
9. BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
10. Disproportionate preponderance of HPV genotypes associated with anogenital warts among HIV-positive MSM.
11. Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants
12. Detection of infectious SARS-CoV-2 in ocular samples is linked to viral load in the nasopharynx
13. Terminal Ileitis as the Exclusive Manifestation of COVID-19 in Children.
14. Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein
15. High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
16. A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
17. Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
18. Anal Ureaplasma spp. positivity among HIV positive men who have sex with men may be associated with high-risk-type HPV infections
19. Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
20. The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer
21. Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination
22. Viral infection in chronic otitis media with effusion in children
23. Reduced sensitivity of antibody tests after omicron infection
24. High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz
25. Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021
26. Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak
27. Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria
28. Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout
29. Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
30. N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro
31. Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model
32. Nature Communications / Impacts of rapid mass vaccination against SARS- CoV2 in an early variant of concern hotspot
33. A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants
34. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
35. Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants
36. Sensitivity and specificity of the antigen-based anterior nasal self-testing programme for detecting SARS-CoV-2 infection in schools, Austria, March 2021
37. Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
38. Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
39. Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay
40. Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study
41. Intragenic Variability of Human Cytomegalovirus Glycoprotein B in Clinical Strains
42. Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley
43. Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
44. Marked Increase in Avidity of SARS-CoV-2 Antibodies 7-8 Months After Infection Is Not Diminished in Old Age
45. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
46. Resistance of mature T cells to oncogene transformation
47. Retroviral Insertional Mutagenesis Can Contribute to Immortalization of Mature T Lymphocytes
48. Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect
49. Human Cytomegalovirus Infection of Leukocyte Populations [with Reply]
50. Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.